ABSTRACT PURPOSE We undertook this study to examine the symptoms, clinical events, and types of health care encounters that preceded the diagnosis of diabetes mellitus in adults, and to examine changes in glycemic control and cardiovascular risk factors in the fi rst year after a diabetes diagnosis.
INTRODUCTION
T he prevalence of diabetes has increased rapidly during the past several decades and is expected to continue to rise. [1] [2] [3] [4] A consistent fi nding of this growing epidemic has been that 35% to 50% of cases of diabetes are undiagnosed. There may be some benefi t in detecting and treating symptomatic and screening for and treating asymptomatic undiagnosed diabetes. [5] [6] [7] [8] [9] [10] Whether this would be best accomplished through more aggressive case fi nding in symptomatic persons or through opportunistic screening of asymptomatic persons is unclear, however. Several quantitative and qualitative studies suggest that a high proportion of patients have diabetes symptoms before diagnosis and that there is considerable heterogeneity in clinical and diagnostic processes that lead to a diabetes diagnosis. [11] [12] [13] [14] [15] [16] The persistent fi nding that many patients are symptomatic for long periods before diabetes diagnosis signals the need to improve clinical pro-
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cesses and case fi nding. On the other hand, the proportion of patients who are truly asymptomatic at the time of diagnosis could be used as an indicator of adequacy of diabetes screening and identifi cation procedures; the higher this proportion is, the better patient and physician awareness of diabetes may be. 17 Currently, the short-term impact of diabetes diagnosis on control of risk factors for macrovascular or microvascular complications is not completely understood. 6, 18 Because more than 70% of adults older than age 40 receiving a diagnosis of type 2 diabetes eventually die of cardiovascular or cerebrovascular disease, 19 a particularly important question is whether diabetes diagnosis leads to improved control of cardiovascular risk factors. Such a fi nding would support the need for more aggressive efforts to improve the diagnosis of diabetes in primary care.
This study was designed to determine how diabetes is diagnosed and initially managed in primary care. We identifi ed the types of clinical encounters, symptoms, and laboratory tests that led to initial diabetes diagnosis, and measured changes in risk factors for microvascular and macrovascular complications in the 12-month period after a new diagnosis.
METHODS

Study Design and Study Site
This historical cohort study was conducted in the HealthPartners Medical Group (HPMG), a Minnesota multispecialty medical group that, in 1996, had 175,000 prepaid enrolled adults receiving primary care from about 130 internists and family physicians at 19 clinics in the Twin Cities metropolitan area. Enrolled patients had a single outpatient medical record kept at their primary care clinic that included all their outpatient clinical data.
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Study Patients
Adults with an initial diagnosis of diabetes made in 1995 or 1996 were identifi ed through a 3-step process. In the fi rst step, all adults who were continuously enrolled and who received 1 or more inpatient or outpatient diabetes diagnosis codes (International Classifi cation of Diseases, Ninth Revision [ICD-9] codes 250.xx) from January 1, 1993, to December 31, 1996 , were identifi ed as potential study patients.
In the second step, those who met previously validated criteria for diagnosis of diabetes from January 1, 1993, to December 31, 1994 , were identifi ed and excluded. This diabetes identifi cation method required either (1) 1 inpatient or 2 outpatient diabetes-specifi c ICD-9 codes (250.xx) or (2) fi lled prescriptions for 1 or more diabetes-specifi c drugs (insulin or sulfonylureas) in calendar year 1993 or 1994. This method of diabetes identifi cation has been validated and has an estimated sensitivity of 0.91, specifi city of 0.99, and positive predictive value of 0.94. 21 In the third step, chart audits were performed for remaining patients to confi rm a new diabetes diagnosis between January 1, 1995, and December 31, 1996. Confi rmation required documentation of either (1) fi rst use of any diabetes-specifi c drug (insulins, sulfonylureas, or biguanides) or (2) laboratory test results that established a diabetes diagnosis based on national diagnostic criteria in effect from 1993 to 1996: initial and confi rmatory fasting plasma glucose concentrations of greater than 140 mg/dL, or a random plasma glucose concentration of greater than 200 mg/dL with symptoms, or a 2-hour plasma glucose value of greater than 200 mg/dL on a 2-hour, 75-g glucose tolerance test. 22 All available data for these patients from before January 1, 1995, were also evaluated, and patients who met these criteria for diabetes diagnosis before that date were excluded.
Defi nition of Variables and Data Collection Data Obtained From Electronic Databases
Administrative and clinical databases were used to obtain data on age; sex; all ICD-9 diagnoses related to diabetes from January 1, 1993, to December 31, 1996 ; fi lled prescriptions during the study period; and laboratory test dates and results for glycated hemoglobin (HbA 1c ), serum glucose, and oral glucose tolerance tests.
All laboratory tests included in the analysis were performed at a single centralized, accredited clinical chemistry laboratory. There were no changes in laboratory assays or procedures for HbA 1c or cholesterol tests during the study period. Tests for HbA 1c were performed using a standard liquid chromatographic method on an analyzer (Variant Hemoglobin Testing System, Bio-Rad Laboratories, Hercules, Calif) with a normal range of 4.5% to 6.1%, and a coeffi cient of variation of 0.58% at an HbA 1c value of 8.8%. 23 Data on fi nger-stick glucose values obtained in the offi ce by nurses were abstracted during the chart audit because these data were not included in electronic databases.
A modifi ed Charlson Comorbidity Index was assigned to each study patient based on a standard set of diagnostic codes assigned over the 12-month period before the date of fi rst diabetes diagnosis. [24] [25] [26] Data Obtained From Medical Record Reviews Medical records were reviewed to identify the specifi c date of initial diabetes diagnosis based on laboratory results. For each patient, this date was used to defi ne 1-year periods before and after the diagnosis. Weight, aspirin use, and blood pressure values were recorded for the 3-month period before the diagnosis and the period DIAGNOSIS AND INITIAL MANAGEMENT OF DIABETES from 9 to 15 months after diagnosis to ascertain change in these measures with time.
Two trained research nurses reviewed medical records. Initial training included instruction based on written chart audit rules; it was followed by joint review of records by the 2 nurses, the project coordinator (LMC), and a physician (PJO) until this group reached consensus on all audit data on 10 consecutive charts. Subsequent agreement between nurses was evaluated on randomly selected charts that were audited twice and was found to exceed 95%.
Among study patients, the proportion with suffi cient data to assess change in risk factors was 66.0% for HbA 1c , 86.9% for blood pressure, 100% for aspirin use, and 87.7% for weight. Changes in lipid control are described below, but multivariate analysis of change in this measure is not reported because of missing data.
Categorization of Circumstances Leading to Diabetes Diagnosis
The research nurses used pretested audit forms to categorize medical encounters related to a new diabetes diagnosis in 2 independent dimensions: visit type and patient symptoms.
Visit type was assigned to 1 of 4 mutually exclusive categories: (1) preventive care (a planned visit for an annual physical examination, Papanicolaou test, etc), (2) preoperative or procedure related (a planned visit to obtain clearance for surgery or a procedure), (3) chronic ongoing condition (eg, a planned visit for asthma, heart disease, depression, hypertension), or (4) acute medical problem (eg, a visit for acute upper respiratory tract infection, pain, or cellulitis).
Patient symptoms at a particular visit were classifi ed into 1 or more of 4 mutually exclusive categories: (1) symptoms related to hyperglycemia (polyuria, polydipsia, polyphagia, weight loss, fatigue, acute blurry vision), (2) symptoms related to long-term complications of diabetes (leg or foot pain, carpal tunnel syndrome, visual deterioration other than acute blurry vision, cataracts), (3) symptoms unrelated to diabetes, or (4) no symptoms.
Statistical Analysis
The 2 statistic and t tests were used to describe differences in the characteristics of various groups of patients. Multivariate modeling of the data was performed using logistic or general linear models to ascertain the relationship of sex, age, comorbidity index, and other independent variables to the main dependent variables: (1) symptom group; (2) change in risk factor status in the 12 months after diagnosis; (3) whether patients reached evidence-based goals for HbA 1c , blood pressure, or aspirin use within 12 months after diagnosis; and (4) type of test used to establish a diagnosis of diabetes. Multivariate models were developed using standard SAS procedures. 27 
Human Subjects Protection
The study protocol was reviewed, approved in advance, and monitored by the institutional review boards of HealthPartners and the Centers for Disease Control and Prevention.
RESULTS
Identifi cation and Characteristics of Adults With Newly Diagnosed Diabetes
The algorithm used to identify study patients with newly diagnosed diabetes is shown in Figure 1 . A total of 504 (94.6%) of 533 study patients had suffi cient data to classify the types of visits and types of symptoms that led to their initial diabetes diagnosis and are the basis of this report. Characteristics of these patients are shown in Table 1 . Not shown in the table are the baseline Charlson Comorbidity Indexes (mean = 0.79), and mean low-density lipoprotein (LDL) cholesterol value of 133 mg/dL, available for only 200 patients (39%). Only 136 (68%) of these 200 individuals had a follow-up LDL-cholesterol measurement within the study period (mean = 129 mg/dL); therefore, no further analysis of LDL-cholesterol data is presented.
Type of Symptoms at the Time of Diagnosis
At diagnosis, 32.3% of the 504 patients had symptoms of hyperglycemia, 7% had symptoms of chronic complications of diabetes, and 61% did not have any diabetesrelated symptoms (ie, they had other or no symptoms). Those with symptoms of hyperglycemia were younger (P = .004), were more likely to be male (P = .002), and had lower comorbidity indexes (P <.001) and higher HbA 1c values at diagnosis (9.9% vs 8.1%, P = .01) than patients who had no symptoms of hyperglycemia.
Type of Visit Leading to Diabetes Diagnosis
About one half of the new diagnoses were made at planned visits, including preventive care visits (21.2%), routine preoperative assessments (5.7%), and chronic disease visits (20.8%). Acute care visits led to diabetes diagnosis in 42.8% of patients. Those receiving the diagnosis at acute care visits had higher mean HbA 1c values at the time of diagnosis than those receiving the diagnosis at scheduled visits (9.4% vs 8.2%, P <.001). Cross-classifi cation by symptoms and by type of visit showed that patients who had hyperglycemia symptoms were more likely than expected to have diabetes diagnosed at acute care visits. Conversely, patients receiving a diagnosis but not having any hyperglycemia DIAGNOSIS AND INITIAL MANAGEMENT OF DIABETES symptoms obtained their diagnosis through preventive or chronic disease care visits.
Type of Tests Used to Diagnose Diabetes
The HbA 1c test was the most frequently used diagnostic test (79%), followed by the fasting glucose test (47%), the 2-hour glucose tolerance test (38%), and the random glucose test (31%) (Figure 2) . A mean of 1.9 glycemia-related tests were done per patient during the 3-month period before the date of diabetes diagnosis.
The percentage of patients with random glucose tests at the time of diagnosis was greater among those with hyperglycemia symptoms than among those without them. Use of other tests near the time of diagnosis did not vary signifi cantly across type of diagnostic visit or type of symptoms at diagnosis. It seems likely that some HbA 1c tests were done for early assessment of glycemic control status, rather than for diagnosis; however, interviews with physicians in this medical group indicate that many view the HbA 1c test as an adequate diagnostic test for diabetes.
Changes in Risk Factors in the Year After Diagnosis
In the year after diagnosis, the overall mean HbA 1c value fell from 8.8% to 7.1% (P <.001). Mean weight decreased from 207.7 to 201.1 lb (P <.001). Signifi cant improvements were also seen in systolic blood pressure (137.5 to 133.2 mm Hg, P <.001), diastolic blood pressure (80.7 to 77.3 mm Hg, P <.001), and aspirin use (from 15.3% to 26.1%, P <.001). Those with diabetes symptoms at diagnosis had greater improvement in HbA 1c (an absolute reduction of 2.8%), but this difference became nonsignifi cant when baseline HbA 1c value was entered in the model. Multivariate models were constructed to adjust observed changes in clinical measures from baseline to the 12-month follow-up for differences in patient age, sex, comorbidity, and baseline clinical measures. These models showed that older age was associated with greater 1-year improvements in systolic blood pressure (F = 4.35, P <.04) and diastolic blood pressure (F = 5.79, P <.02) and that systolic blood pressure improved signifi cantly more in men than in women (F = 4.59, P <.04) (results not shown). Change in HbA 1c was not signifi cantly related to age, sex, or baseline comorbidity.
A total of 42% of study patients were treated with insulin (5%), oral hypoglycemic agents (39%), or both (2%) within 12 months of initial diabetes diagnosis. Figure 3 . The largest improvement was in HbA 1c , for which the percentage of patients with a value less than 7% doubled from 29% to 58%. Less substantial gains in aspirin use and blood pressure control were also observed.
DISCUSSION
Few studies have systematically examined the clinical circumstances that lead to diabetes diagnosis and subsequent changes in care in primary care. Two of our key fi ndings may have important implications for detecting and screening for diabetes in primary care: (1) 39% of patients with undiagnosed diabetes had diabetes-related symptoms at the time of detection, and 43% received their diagnosis at visits for acute care; and (2) clinically signifi cant improvements in HbA 1c levels, systolic and diastolic blood pressures, aspirin use, and weight occurred within 1 year of a new diagnosis of diabetes.
The fi rst of these fi ndings suggests that improved awareness of symptoms on the part of patients and their clinicians may have a substantial yield; the second fi nding is of great interest because the improvements were large enough to decrease substantially the risk of diabetes complications if maintained over time. In the UK Prospective Diabetes Study (UKPDS), each 1% decrease in HbA 1c value yielded about a 30% reduction in incidence of microvascular complications plus about a 16% drop in incidence of macrovascular complications. 29, 30 The recent fi nding of benefi cial 16-to 18-year-long legacy effects of good blood pressure and glucose control increases the clinical importance of these observed short-term risk reductions. 31, 32 In contrast to previous studies that showed improved postdiagnosis diabetes control with the use of systematic research interventions, 13, 16 our study shows clinically important gains achieved in routine primary care practice.
The observed improvements in HbA 1c values, blood pressure, weight, and aspirin use exceeded expected changes based on local secular trends, which have been quantifi ed in previous publications. 33, 34 For example, the observed HbA 1c change of -1.8% over 12 months substantially exceeded the improvement trend of -0.2% per year in all adults with diabetes from 1994 to 1996. Similarly, the decrease in systolic and diastolic blood pressures observed over 12 months in patients with newly diagnosed diabetes exceeded the blood pressure reduction achieved over 18 months in other local clinics that were focusing extensive resources on improved blood pressure control. 33, 35 Only small improvements in control of LDL-cholesterol occurred in the study population during the years of the study; more dramatic changes in LDL-cholesterol values have been observed recently. 36 Our fi ndings extend results of previous studies done in the United Kingdom and the United States that show about 50% to 80% of adults with newly diagnosed diabetes have hyperglycemia symptoms that antedate the diagnosis. 11, 13, 15 A recent qualitative study of adults with newly diagnosed diabetes suggests that patients often do not associate classic diabetes symptoms with the disease and have limited understanding of diabetes before their diagnosis, even when relatives have diabetes. 17 Other studies have described the characteristics of adults whose diabetes was fi rst diagnosed through systematic offi ce-based screening. 13, 37, 38 The overall yield from systematic screening of patients attending clinics is low, fewer men than women accept an invitation to be screened, and those with newly detected diabetes frequently have uncontrolled cardiovascular risk factors. 39 A small study of 56 Veterans Administration patients with diabetes diagnosed through screening showed no blood pressure improvement and generally ineffective glucose management in the year after diagnosis. 18 Our fi ndings are quite different; both those with and those without symptoms at diagnosis had signifi cantly improved glucose control and cardiovascular risk factor control within 1 year.
The physicians in this practice used a wide range of tests to diagnose diabetes. Patients with hyperglycemia symptoms were more likely to have a random glucose test, as might be expected on clinical grounds. 40 Since the study was done, changes in diagnostic criteria and in recommended treatment goals for diabetes have occurred; these changes underscore the importance of aggressive efforts to diagnose diabetes and promptly control risk factors for complications. 41 Several factors limit the interpretation of these data. First, the study population was drawn from a single large medical group. Local demographics and relatively high local levels of diabetes awareness among both patients and physicians may have affected the results. If this is the case, the proportion of patients with newly diagnosed diabetes who are already symptomatic before the diagnosis might be even higher in other settings. Second, the complex web of events leading to diabetes diagnosis is diffi cult to unravel, and we had no way to classify patient self-diagnosis of diabetes, which has been described in a small proportion of patients in previous studies 17 ; however, we developed an a priori classifi cation system that allowed 504 of the 533 study patients to be classifi ed in a reproducible way by symptoms and type of visit.
Despite these limitations, the data clearly show that for nearly one half the study patients, diagnosis of diabetes was accomplished not by screening asymptomatic patients, but rather by clinical recognition of classic short-and long-term diabetes-related symptoms at visits scheduled for reasons unrelated to diabetes. After diagnosis, patients had signifi cant reductions in HbA 1c values and other risk factors that could not be attributed to secular trends in diabetes care. Timely diabetes diagnosis is thus likely to have a benefi cial impact on patients' future clinical course by decreasing the amount of time they are exposed to high levels of adverse risk factors. 16, 31, 42 More aggressive and systematic efforts to diagnose diabetes earlier in its clinical course should be seriously considered as clinical policy.
